Stewart, P., & Tomlinson, J. (2009). Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: Is the target liver, fat, or both?
Dyfyniad Arddull ChicagoStewart, P., and J. Tomlinson. Selective Inhibitors of 11beta-hydroxysteroid Dehydrogenase Type 1 for Patients with Metabolic Syndrome: Is the Target Liver, Fat, or Both? 2009.
Dyfyniad MLAStewart, P., and J. Tomlinson. Selective Inhibitors of 11beta-hydroxysteroid Dehydrogenase Type 1 for Patients with Metabolic Syndrome: Is the Target Liver, Fat, or Both? 2009.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.